Spanning regulatory and commercial realms, DRG brings to you 4 strategy recommendations that medtech firms can’t ignore in 2020

  • The topics selected reflect key drivers of the evolving medtech commercial landscape and consider impacts on patients as well as the cost of doing business
  • The recommendations are based on input from DRG’s medtech experts, including analysts, data experts, consultants, account managers, and executives and considered customer requests, secondary research, report research & data analysis
  • While the events and macrotrends affecting these strategies will unfold over years, the focus of this piece is on actions that medtech firms can take in 2020

Picturing the hidden patient

View Now